• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者对肠道微生物组研究和临床护理中粪便采样的态度表明他们积极参与并有改进的空间。

Patient attitudes towards faecal sampling for gut microbiome studies and clinical care reveal positive engagement and room for improvement.

机构信息

Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

PLoS One. 2021 Apr 8;16(4):e0249405. doi: 10.1371/journal.pone.0249405. eCollection 2021.

DOI:10.1371/journal.pone.0249405
PMID:33831035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8031379/
Abstract

Faecal sample collection is crucial for gut microbiome research and its clinical applications. However, while patients and healthy volunteers are routinely asked to provide stool samples, their attitudes towards sampling remain largely unknown. Here, we investigate the attitudes of 780 Dutch patients, including participants in a large Inflammatory Bowel Disease (IBD) gut microbiome cohort and population controls, in order to identify barriers to sample collection and provide recommendations for gut microbiome researchers and clinicians. We sent questionnaires to 660 IBD patients and 112 patients with other disorders who had previously been approached to participate in gut microbiome studies. We also conducted 478 brief interviews with participants in our general population cohort who had collected stool samples. Statistical analysis of the data was performed using R. 97.4% of respondents reported that they had willingly participated in stool sample collection for gut microbiome research, and most respondents (82.9%) and interviewees (95.6%) indicated willingness to participate again, with their motivations for participating being mainly altruistic (57.0%). Responses indicated that storing stool samples in the home freezer for a prolonged time was the main barrier to participation (52.6%), but clear explanations of the sampling procedures and their purpose increased participant willingness to collect and freeze samples (P = 0.046, P = 0.003). To account for participant concerns, gut microbiome researchers establishing cohorts and clinicians trying new faecal tests should provide clear instructions, explain the rationale behind their protocol, consider providing a small freezer and inform patients about study outcomes. By assessing the attitudes, motives and barriers surrounding participation in faecal sample collection, we provide important information that will contribute to the success of gut microbiome research and its near-future clinical applications.

摘要

粪便样本采集对于肠道微生物组研究及其临床应用至关重要。然而,尽管经常要求患者和健康志愿者提供粪便样本,但他们对采样的态度在很大程度上仍然未知。在这里,我们调查了 780 名荷兰患者的态度,包括炎症性肠病(IBD)肠道微生物组队列和人群对照的参与者,以确定采样的障碍,并为肠道微生物组研究人员和临床医生提供建议。我们向 660 名 IBD 患者和 112 名曾被邀请参加肠道微生物组研究的其他疾病患者发送了问卷。我们还对我们的一般人群队列中收集粪便样本的 478 名参与者进行了简短访谈。使用 R 对数据进行了统计分析。97.4%的受访者报告说,他们自愿参与了肠道微生物组研究的粪便样本采集,大多数受访者(82.9%)和受访者(95.6%)表示愿意再次参与,他们参与的动机主要是利他主义(57.0%)。调查结果表明,在家用冰箱中长时间储存粪便样本是参与的主要障碍(52.6%),但清楚地解释采样程序及其目的增加了参与者采集和冷冻样本的意愿(P=0.046,P=0.003)。为了解决参与者的担忧,建立队列的肠道微生物组研究人员和尝试新粪便检测的临床医生应提供明确的说明,解释其方案背后的原理,考虑提供一个小冰箱,并告知患者研究结果。通过评估参与粪便样本采集的态度、动机和障碍,我们提供了重要的信息,这将有助于肠道微生物组研究及其不久的将来的临床应用的成功。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/8031379/f4c51ef86e15/pone.0249405.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/8031379/f4c51ef86e15/pone.0249405.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/8031379/f4c51ef86e15/pone.0249405.g001.jpg

相似文献

1
Patient attitudes towards faecal sampling for gut microbiome studies and clinical care reveal positive engagement and room for improvement.患者对肠道微生物组研究和临床护理中粪便采样的态度表明他们积极参与并有改进的空间。
PLoS One. 2021 Apr 8;16(4):e0249405. doi: 10.1371/journal.pone.0249405. eCollection 2021.
2
Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling.直肠拭子、手套尖和参与者采集粪便技术在肠道微生物组采样中的比较。
BMC Microbiol. 2021 Jan 14;21(1):26. doi: 10.1186/s12866-020-02080-3.
3
Methods for Improving Human Gut Microbiome Data by Reducing Variability through Sample Processing and Storage of Stool.通过粪便样本处理和储存减少变异性来改善人类肠道微生物组数据的方法
PLoS One. 2015 Aug 7;10(8):e0134802. doi: 10.1371/journal.pone.0134802. eCollection 2015.
4
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
5
Systematic Analysis of Impact of Sampling Regions and Storage Methods on Fecal Gut Microbiome and Metabolome Profiles.系统分析采样区域和储存方法对粪便肠道微生物组和代谢组谱的影响。
mSphere. 2020 Jan 8;5(1):e00763-19. doi: 10.1128/mSphere.00763-19.
6
3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammation.3D 打印直肠拭子用于评估肠道微生物组、代谢组和炎症。
Sci Rep. 2024 Jul 18;14(1):16613. doi: 10.1038/s41598-024-67457-0.
7
Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study.探索肠道微生物组特征对炎症性肠病患者强化治疗的预测价值:一项 10 年随访研究。
Inflamm Bowel Dis. 2024 Oct 3;30(10):1642-1653. doi: 10.1093/ibd/izae064.
8
Gut microbiome analysis by post: Evaluation of the optimal method to collect stool samples from infants within a national cohort study.基于邮送的粪便微生物组分析:在全国队列研究中评估从婴儿收集粪便样本的最佳方法。
PLoS One. 2019 Jun 12;14(6):e0216557. doi: 10.1371/journal.pone.0216557. eCollection 2019.
9
Reliability of a participant-friendly fecal collection method for microbiome analyses: a step towards large sample size investigation.一种方便参与者的粪便收集方法用于微生物组分析的可靠性:迈向大样本量研究的一步。
BMC Microbiol. 2018 Sep 6;18(1):110. doi: 10.1186/s12866-018-1249-x.
10
The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.微生物群反映了儿童期起病的炎症性肠病的诊断情况,并可预测疾病严重程度。
Scand J Gastroenterol. 2019 Aug;54(8):969-975. doi: 10.1080/00365521.2019.1644368. Epub 2019 Jul 22.

引用本文的文献

1
Feasibility and acceptability of conducting a birth cohort study during the COVID-19 pandemic: a mixed-methods study.在新冠疫情期间开展出生队列研究的可行性与可接受性:一项混合方法研究
BMC Pregnancy Childbirth. 2025 Jul 16;25(1):767. doi: 10.1186/s12884-025-07850-3.
2
Perceived usability, acceptability, and feasibility of stool-based qPCR TB diagnostics: perspectives from healthcare providers in Manhiça District, southern Mozambique.基于粪便的qPCR结核病诊断方法的感知可用性、可接受性和可行性:来自莫桑比克南部曼希卡区医疗服务提供者的观点
BMC Infect Dis. 2025 May 26;25(1):757. doi: 10.1186/s12879-025-11117-9.
3
Circulating Exosomal Proteins as New Diagnostic Biomarkers for Colorectal Cancer (EXOSCOL01): A Pilot Case-Controlled Study Focusing on MMP14 Potential.

本文引用的文献

1
The recognition and attitudes of postgraduate medical students toward fecal microbiota transplantation: a questionnaire study.研究生医学生对粪便微生物群移植的认知与态度:一项问卷调查研究
Therap Adv Gastroenterol. 2019 Sep 2;12:1756284819869144. doi: 10.1177/1756284819869144. eCollection 2019.
2
In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation.寻找粪便捐赠者:一项多中心研究,调查潜在捐赠者对粪便微生物群移植的预先知识、看法、动机和阻碍因素。
Gut Microbes. 2020;11(1):51-62. doi: 10.1080/19490976.2019.1611153. Epub 2019 May 23.
3
循环外泌体蛋白作为结直肠癌的新型诊断生物标志物(EXOSCOL01):一项聚焦MMP14潜力的病例对照试点研究。
J Clin Lab Anal. 2025 May;39(9):e70016. doi: 10.1002/jcla.70016. Epub 2025 Apr 17.
4
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.先行走,再奔跑:来自 PROCLAIM 研究的可行性挑战和经验教训,该研究是一项关于 COVID-19 期间米索前列醇预防复发性艰难梭菌的多中心随机对照试验。
Anaerobe. 2023 Apr;80:102699. doi: 10.1016/j.anaerobe.2023.102699. Epub 2023 Jan 23.
5
Standards for Collection, Preservation, and Transportation of Fecal Samples in TCM Clinical Trials.中医临床试验中粪便样本采集、保存和运输的标准。
Front Cell Infect Microbiol. 2022 Apr 20;12:783682. doi: 10.3389/fcimb.2022.783682. eCollection 2022.
6
Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome.系统评价:林奇综合征个体中结直肠肿瘤的非内镜监测。
Aliment Pharmacol Ther. 2022 Apr;55(7):778-788. doi: 10.1111/apt.16824. Epub 2022 Feb 18.
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
免疫介导的炎症性疾病的肠道微生物组比较研究——是否存在共同的菌群失调?
Microbiome. 2018 Dec 13;6(1):221. doi: 10.1186/s40168-018-0603-4.
4
Microbiota and cancer immunotherapy: in search of microbial signals.微生物群与癌症免疫疗法:寻找微生物信号
Gut. 2019 Mar;68(3):385-388. doi: 10.1136/gutjnl-2018-317220. Epub 2018 Dec 8.
5
Dietary Interventions to Modulate the Gut Microbiome-How Far Away Are We From Precision Medicine.饮食干预调节肠道微生物组——我们离精准医学还有多远。
Inflamm Bowel Dis. 2018 Sep 15;24(10):2142-2154. doi: 10.1093/ibd/izy080.
6
A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.短链脂肪酸通过肠道菌群与黏膜免疫系统互作调控肠道稳态及炎症性肠病
Inflamm Bowel Dis. 2018 Feb 15;24(3):558-572. doi: 10.1093/ibd/izx029.
7
Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.系统评价和荟萃分析:粪便微生物移植治疗活动期溃疡性结肠炎。
Inflamm Bowel Dis. 2017 Oct;23(10):1702-1709. doi: 10.1097/MIB.0000000000001228.
8
Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation.肠道黏液微生物群的组成变化先于结肠炎诱导的炎症发作。
Inflamm Bowel Dis. 2017 Jun;23(6):912-922. doi: 10.1097/MIB.0000000000001118.
9
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.肠道微生物群功能可预测炎症性肠病对抗整合素生物疗法的反应。
Cell Host Microbe. 2017 May 10;21(5):603-610.e3. doi: 10.1016/j.chom.2017.04.010.
10
Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations.分析活细菌有助于粪便微生物群移植的准备工作。
PLoS One. 2017 Jan 26;12(1):e0170922. doi: 10.1371/journal.pone.0170922. eCollection 2017.